XT
ZVRA icon

XTX Topco’s Zevra Therapeutics ZVRA Stock Holding History

XTX Topco’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
+134,119
New +$1.49M 0.02% 1137
2025
Q4 		– Sell
-66,381
Closed -$631K – 3892
2025
Q3 		$631K Buy
+66,381
New +$666K 0.03% 898
2024
Q4 		– Sell
-13,551
Closed -$94K – 3030
2024
Q3 		$94K Buy
+13,551
New +$92K 0.01% 1616

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's ZVRA Position: Q2 2026 in Review

XTX Topco opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 134,119 shares worth $1.92M. The stake represents 0.02% of the portfolio and ranks #1137 among its holdings. This is a return to the name: XTX Topco previously reported a position in ZVRA as recently as Q3 2025.

XTX Topco first reported a position in ZVRA in Q3 2024 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • XTX Topco held 134,119 shares of Zevra Therapeutics worth $1.92M as of Q2 2026.
  • Zevra Therapeutics was a new XTX Topco position in Q2 2026.
  • Zevra Therapeutics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1137 holding.
  • XTX Topco first reported a position in Zevra Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.